International Conference
Tumour biomarkers: From discovery to clinical applications
The introduction of tumor biomarkers (TB) has revolutionized the clinical practice of oncology. TB are molecules that represent biological alterations produced directly by the tumor or by the body’s response to the tumor.The ideal biomarker for clinical use should have easy means of measurement, high accuracy for its intended outcome, and should provide improvement of decision-making.
The "Tumour biomarkers: From discovery to clinical applications" conference covers a wide range of apsects regarding the state-of-the-art in cancer biomarker research though 8 sessions:
Session 1: miRNAs as emerging cancer biomarkers
Session 2: Circulating tumor cells
Session 3: Translating molecular pathways into novel cancer biomarkers
Session 4: Novel technological advances in biomarker discovery
Session 5: Biological tumor markers of female reproductive organ malignancies
Session 6: The future of cancer biomarkers
Session 7: Novel approaches for urologic tumor biomarker discovery
Session 8: Novel biomarkers for leukemia and lymphoma
